Description
Photoselective vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia (BPH) was introduced in approximately 2004 in North America. Although the diffusion of the KTP laser, used for PVP, has been quite limited in Canada, there is growing interest among some urologists and provincial governments. This report reviews the safety, efficacy and effectiveness of PVP compared to the existing "gold standard," transurethral resection of the prostate (TURP), and consider the potential social, fiscal and economic factors involved in providing PVP as a funded service.
Updated
May 1, 2007
Tags
Title and publication information
Type
Extent
83 pages
Frequency
Once
Publisher / Creator Information
Creator
Publisher
Alberta Expert Review Panel for Blood Borne Viral Infections in Health Care Workers
Contributor
Place of Publication
Subject Information
Topic
Resource Dates
Date Created
2007-05-01
Date Added
2017-09-28T20:38:41.551909
Date Modified
2007-05-01
Date Issued
2007-05-01